14
Nov
2024

RFK Jr. to HHS. I Was Wrong

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Lilly Beats Novo, Amgen’s So-So Obesity Data & Atlas Stays Lean & Mean
Dr. Oz to CMS, Amgen and Pfizer Get New CSOs, & SubQ Keytruda Arrives
What Will Trump Do? Look at the Record
Aliada’s Mega Return, GSK & AbbVie Eye T-Cell Engagers, and IPO Scorecard